Deficiency of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1 accelerates atherogenesis in apolipoprotein E-deficient mice

Biochemical and Biophysical Research Communications

Volumn 396, Issue 2, 2010, Pages 359-363

  Akyürek, Levent M ^a,b   Boehm, Manfred ^a   Olive, Michelle ^a   Zhou, Alex Xianghua ^b   San, Hong ^a   Nabel, Elizabeth G ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Aorta; Atherosclerosis; Neointima; Proliferation

Indexed keywords

APOLIPOPROTEIN E; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HYPERCHOLESTEROLEMIA; LIPID DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THORACIC AORTA;

ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CELL PROLIFERATION; CHOLESTEROL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DIET, ATHEROGENIC; MICE; MICE, MUTANT STRAINS;

MUS;

EID: 77952746347     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.04.097     Document Type: Article

References (19)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
2. Sherr C.J., and Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9 (1995) 1149-1163
3. Yang Z., Simari R.D., Tanner F., Stephan D., Nabel G.J., and Nabel E.G. Gene transfer approaches to the regulation of vascular cell proliferation. Semin. Interv. Cardiol. 1 (1996) 181-184
4. Tanner F.C., Yang Z.Y., Duckers E., Gordon D., Nabel G.J., and Nabel E.G. Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ. Res. 82 (1998) 396-403
5. Tanner F.C., Boehm M., Akyürek L.M., San H., Yang Z.Y., Tashiro J., Nabel G.J., and Nabel E.G. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation. Circulation 101 (2000) 2022-2025
6. Condorelli G., Aycock J.K., Frati G., and Napoli C. Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice. FASEB J. 15 (2001) 2162-2170
7. Chen D., Krasinski K., Sylvester A., Chen J., Nisen P.D., and Andres V. Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery. J. Clin. Invest. 99 (1997) 2334-2341
8. McArthur J.G., Qian H., Citron D., Banik G.G., Lamphere L., Gyuris J., Tsui L., and George S.E. p27-p16 Chimera: a superior antiproliferative for the prevention of neointimal hyperplasia. Mol. Ther. 3 (2001) 8-13
9. Tsui L.V., Camrud A., Mondesire J., Carlson P., Zayek N., Camrud L., Donahue B., Bauer S., Lin A., Frey D., Rivkin M., Subramanian A., Falotico R., Gyuris J., Schwartz R., and McArthur J.G. p27-p16 fusion gene inhibits angioplasty-induced neointimal hyperplasia and coronary artery occlusion. Circ. Res. 89 (2001) 323-328
10. Nabel E.G., Boehm M., Akyürek L.M., Yoshimoto T., Crook M.F., Olive M., San H., and Qu X. Cell cycle signaling and cardiovascular disease. Cold Spring Harb. Symp. Quant. Biol. 67 (2002) 163-170
11. Boehm M., Olive M., True A.L., Crook M.F., San H., Qu X., and Nabel E.G. Bone marrow-derived immune cells regulate vascular disease through a p27(Kip1)-dependent mechanism. J. Clin. Invest. 114 (2004) 419-426
12. Sata M., Takahashi A., Tanaka K., Washida M., Ishizaka N., Ako J., Yoshizumi M., Ouchi Y., Taniguchi T., Hirata Y., Yokoyama M., Nagai R., and Walsh K. Mouse genetic evidence that tranilast reduces smooth muscle cell hyperplasia via a p21(WAF1)-dependent pathway. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1305-1309
13. Kiyokawa H., Kineman R.D., Manova-Todorova K.O., Soares V.C., Hoffman E.S., Ono M., Khanam D., Hayday A.C., Frohman L.A., and Koff A. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85 (1996) 721-732
14. Carmeliet P. Proteinases in cardiovascular aneurysms and rupture: targets for therapy?. J. Clin. Invest. 105 (2000) 1519-1520
15. Prescott M.F., Sawyer W.K., Von Linden-Reed J., Jeune M., Chou M., Caplan S.L., and Jeng A.Y. Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury. Ann. N. Y. Acad. Sci. 878 (1999) 179-190
16. Pyo R., Lee J.K., Shipley J.M., Curci J.A., Mao D., Ziporin S.J., Ennis T.L., Shapiro S.D., Senior R.M., and Thompson R.W. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J. Clin. Invest. 105 (2000) 1641-1649
17. Diez-Juan A., and Andres V. The growth suppressor p27(Kip1) protects against diet-induced atherosclerosis. FASEB J. 15 (2001) 1989-1995
18. Merched A.J., and Chan L. Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis. Circulation 110 (2004) 3830-3841
19. Chang M.W., Barr E., Lu M.M., Barton K., and Leiden J.M. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J. Clin. Invest. 96 (1995) 2260-2268